More than 40 thousand people, including fire and rescue workers, were exposed to toxic dust in the wake of the attacks on the World Trade Center in New York City in September, 2001. Fast-forward more than a decade, and nearly a quarter of those first responders still have breathing issues. Dr. Norman Edelman, chief medical officer of the American Lung Association, joins host Dr. Shira Johnson to disuss what needs to be done for those who continue to suffer, as well as how children living in nearby neighborhoods have also been affected. The two also look at air quality and allergy and its affect on Americans.
“9-11 Cough” & Persistent Lung Ailments
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
More than 40 thousand people, including fire and rescue workers, were exposed to toxic dust in the wake of the attacks on the World Trade Center in New York City in September, 2001. Fast-forward more than a decade, and nearly a quarter of those first responders still have breathing issues. Dr. Norman Edelman, chief medical officer of the American Lung Association, joins host Dr. Shira Johnson to disuss what needs to be done for those who continue to suffer, as well as how children living in nearby neighborhoods have also been affected. The two also look at air quality and allergy and its affect on Americans.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
Love Story: Lipid Education for Women’s Heart Health
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
Navigating Myasthenia Gravis in Adolescents and Young Adults
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?